Timo-Daniel Voß

Dr. Timo-Daniel Voß

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2022 in Cells
Verified
Journal Article
Open access
PDF file
Ranferi Ocaña-GuzmanRanferi Ocaña-Guzman
Ranferi Ocaña-Guzman
LRLUCERO A RAMON-LUING
LUCERO A RAMON-LUING
DADiana Michelle Michelle Rodriguez Alvarado
Diana Michelle Michelle Rodriguez Alvarado
TVTimo-Daniel Voß
Timo-Daniel Voß
TFTina Fuchs
Tina Fuchs
Leslie Chavez-GalanLeslie Chavez-Galan
Leslie Chavez-Galan
In recent years, a growing body of evidence has shown the presence of a subpopulation of macrophages that express CD3, especially in the context of mycobacterial infections. Despite these findings, the function of these cells has been poorly understood. Furthermore, the low frequency of CD3+ macrophages in humans limits the study of this subpopulation. This work aimed to evaluate the expression of CD3 in a murine macrophage cell line and its potential for the study of CD3 signaling. The murine macrophage cell line RAW was used to evaluate CD3 expression at the transcriptional and protein levels and the effect of in vitro infection with the Mycobacterium bovis Bacillus Calmette-Guérin (BCG) on these. Our data showed that RAW macrophages express CD3, both the ε and ζ chains, and it is further increased at the transcriptional level after BCG infection. Furthermore, our data suggest that CD3 can be found on the cell surface and intracellularly. However, this molecule is internalized constantly, mainly after activation with anti-CD3 stimulus, but interestingly, it is stably maintained at the transcriptional level. Finally, signaling proteins such as NFAT1, c-Jun, and IKK-α are highly expressed in RAW macrophages. They may play a role in the CD3-controlled signaling pathway to deliver inflammatory cytokines such as TNF and IL-6. Our study provides evidence to support that RAW cells are a suitable model to study the function and signaling of the CD3 complex in myeloid cells.

8 July 2025
Verified
Book Chapter
Closed access
PDF file
TVTimo-Daniel Voß
Timo-Daniel Voß
LHLucy Hezinger
Lucy Hezinger
TKThomas A. Kufer
Thomas A. Kufer

1 September 2023 in Science Advances
Verified
Journal Article
Open access
MNMichael Neumaier
Michael Neumaier
SGSophie Giesler
Sophie Giesler
VAVolker Ast
Volker Ast
MRMathis Roemer
Mathis Roemer
TVTimo-Daniel Voß
Timo-Daniel Voß
TFTina Fuchs
Tina Fuchs
This report demonstrates a novel class of innate immune cells designated “variable immunoreceptor–expressing myeloids” (VIREMs). Using single-cell transcriptomics and genome-wide epigenetic profiling, we establish that VIREMs are myeloid cells unrelated to lymphocytes. We visualize the phenotype of B-VIREMs that are capable of genetically recombining and expressing antibody genes, the exclusive hallmark function of B lymphocytes. These cells, designated B-VIREMs, display monoclonal antibody cell surface signatures and regularly circulate in the blood of healthy individuals. Single-cell data reveal clonal expansion of circulating B-VIREMs as a dynamic response to disease stimuli. Live-cell imaging models suggest that B-VIREMs load their own Fc receptors with endogenous antibodies during vesicle transport to the cell surface. A first cloned B-VIREM–derived antibody (Vab1) specifically binds stomatin, a ubiquitous scaffold protein that is strictly expressed intracellularly, allowing Vab1-bearing macrophages to phagocytose cell debris without requiring prior opsonization. Our results suggest important antigen-specific tissue maintenance functionalities in these innate immune cells.

29 November 2025 in bioRxiv
Verified
Preprint
Open access
TVTimo-Daniel Voß
Timo-Daniel Voß
CWChristoph Winterberg
Christoph Winterberg
ABAdrian Beck
Adrian Beck
CGClarissa Gottschild
Clarissa Gottschild
LMLeonie Mueller
Leonie Mueller
TKThomas A. Kufer
Thomas A. Kufer
NLRP10 is an atypical member of the NOD-like receptor (NLR) family because it lacks a leucine-rich repeat domain at its C-terminus. Recently, NLRP10 has been shown to form an inflammasome, however, the mechanism and the trigger of activation remain elusive. Here, we show that in human epithelial cells and keratinocytes NLRP10 oligomerises in response to the stressor m -3M3FBS. NLRP10 co-localises with ASC upon overexpression, but ASC nucleation and recruitment were different to other NLRPs. While neither ATP hydrolysis nor the pyrin domain were required, the C-terminal tail region (aa 584-655) was both necessary and sufficient for oligomerisation. Generation of chimeric proteins showed that the function of the tail is conserved between human and mouse NLRP10 in respect to aggregation but convers different protein stability. Changes in the subcellular localisation of NLRP10 and oligomerization were dependent on the presence of evolutionarily conserved lysine residues in the tail region, which localise the majority of NLRP10 at lipid droplets. Our study identifies the C-terminal basic tail of NLRP10 as a key regulatory element for oligomerisation and localisation at lipid interfaces. These findings underline differences of NLRP10 activation in respect to other inflammasome forming NLRPs and suggest a role of lipids in NLRP10 activation.

26 June 2026 in EMBO Reports
Verified
Journal Article
Open access
PDF file
TVTimo-Daniel Voß
Timo-Daniel Voß
CWChristoph Winterberg
Christoph Winterberg
ABAdrian Beck
Adrian Beck
CGClarissa Gottschild
Clarissa Gottschild
LMLeonie Mueller
Leonie Mueller
TKThomas A. Kufer
Thomas A. Kufer
NLRP10 is an atypical member of the NLR family because it lacks a leucine-rich repeat domain at its C-terminus. Here, we show that in human epithelial cells and keratinocytes NLRP10 oligomerises in response to m -3M3FBS and SC-10 treatment. NLRP10 co-localises with ASC upon overexpression, but ASC nucleation and recruitment are different to NLRP3. While neither ATP hydrolysis nor the pyrin domain is required, the C-terminal tail region is both necessary and sufficient for oligomerisation. The generation of chimeric proteins shows that the tail region of human and mouse NLRP10 has a conserved function in oligomerisation but determines different protein stabilities. Changes in the subcellular localisation of NLRP10 and oligomerisation are dependent on the presence of evolutionarily conserved lysine residues in the tail region, which localise the majority of NLRP10 to lipid droplets. Our study identifies the C-terminal basic tail of NLRP10 as a key regulatory element for oligomerisation and localisation at lipid interfaces. These findings underline differences in NLRP10 activation with respect to other inflammasome-forming NLRPs and suggest a role of lipids in NLRP10 activation.